Experimental
- more scientifically ___
- used for ___ and ___ studies
- may have limited ___ ___ (generalizability) if subject eligibility is strict
- not always feasible due to ___ issues - Answers rigourous
intervention/prevention
external validity
ehtical
Observational
- ___ scientifically rigourous
- used for ___ studies
- some __ issues - Answers less
etiological
ethical
Strengths and Weaknesses: RCT
S:
* Demostrate the ___-___ relationship
- uses experimental mode: "____ ____" for all studies
** control __
** random allocation elimanates __ bias in treatment comparison
- may produce __ and __ results than observational
W:
- often more costly in __ and __
- only appropiate for some research questions
* many research questions are suited for experimental designs due to ___ issues and __ outcomes
- many questions are not suitable for ___
- ___ interventions may be different from common practice
- may have limited ___ _____ (generalizibility) due to volunteers, elibgibiity criteria, and ___ of ___ up
- Answers cause-effect
gold standard
exposure
selection
faster/cheaper
time/money
ethical/rare
blinding
standaradized
external validity/loss of follow up
Strengths and Weaknesses: Case-Control Studies
S:
- efficient for ___/___ diseases with long ___/___ periods
* ___ and ___ to complete --> don't have to wait for the patients to get __ bc they are ___
- can evaluate many ___ factors for the same disease
* good for diseases with which ___ is known
W:
- cannot calculate ___ (___) of a disease directly
- inefficient for rare/unusal _____ (____ of nuclear meltdown)
- vulnerable to bias because of ___ nature
- difficult to infer ___ relationship between exposure and disease - Answers
rare/unusual/induction/latent
easy/quick/sick/sick
risk
little
, risk(incidence)
exposure(exposure)
retrospective
temporal
Strengths and weaknesses: Cohort Studies
S:
- logical approach to studies of ___ or ____ of treatment (____ precedes ___) E _______ D
- ____ measurments of exposure in relation to disease ____
- does not rely on __ for information about exposure status; avoids bias due to __ recall
- measures __ and thus permits ___ estimation of ___
* since cohort studies begin with ____ subjects, potential bias due to selective ___ is eliminated
- can yield information on associations of ___ with the multiple diseases at a time
- designs proves more about the __ history of the disease
- best to study the effects of rare ___ with ___ cases among the exposed - Answers causation/effects
(cause preceedes effect
E--->D
-prospective/occurence
memory/selective
incidence/direct/risk
*nondiseased/survival
- exposure
- natural
exposure/frequent
Weaknesses: Cohort
**** ______
- information collected from __ number of subjects
- study personnel employed for ___ period of time
- tracing of subjects who __ overtime
- may be too ___ for rare disease
*****_____
- findings not __ obtained
- variations of personnel overtime
- variations in data collection __ overtime
- may take too long for long ___
- vulnerability to loss of __ overtime - Answers expense
large
long
expensive
time
quickly
methods
induction
subjects
Prospective vs Retrospective Cohort:
Pro (___ ) study:
- starts at time ___ (beginning of follow up) with cohort ___ of disease, exposed are ascertained as
they come and observe cohort prospectively in real time until outcome evaluated (___ of follow up)
Advantages:
- more control over selection of ____ and ____ and ____ measure than retro
Weaknesses:
- more ___
- ____ exposure
- limited to one ___ variable - Answers concurrent
zero/free/end
subjects/exposure/outcome